Skip to main content

Military Health System

Test of Sitewide Banner

This is a test of the sitewide banner capability. In the case of an emergency, site visitors would be able to visit the news page for addition information.

How the military stays ready during disease outbreaks

Image of Headshot of Dr. Sanchez. Dr. Toti Sanchez is a senior scientist and deputy chief at Armed Forces Health Surveillance Branch

A Q & A with Dr. Jose L. (Toti) Sanchez, Senior Scientist & Deputy Chief, AFHSB


What is your focus area?

A major component of my work is to ensure that major health surveillance program plans and initiatives are current and reflect alignment with the Defense Health Agency’s Strategic Plan. Under the guidance of AFHSB’s Chief, I also help to build strong scientific and collaborative relationships within the Public Health Directorate.

How do you monitor disease outbreaks?

I spend a significant amount of time monitoring the many peer-reviewed, governmental and international association reports. I also analyze the disease outbreak reports and coordinate data gathering and report generation from AFHSB’s Global Emerging Infections Surveillance, Epidemiology and Analysis), and Integrated Biosurveillance  sections.

In my role as Senior Scientist at AFHSB, I serve on the Infectious Disease Clinical Research Program Operational Steering Committee, a “think-tank” committee of experts who provide guidance on military-relevant research efforts in support of the U.S. military’s force health protection needs. I also work as an instructor at the Uniformed Services University of the Health Sciences. I ensure students and residents in public health learn the basic skills of outbreak investigation, associated surveillance, and research initiatives.

How do you support AFHSB's response to COVID-19?

The COVID-19 pandemic has placed an immense workload on our AFHSB staff to produce analyses and reports for DHA leadership, senior DOD officials, the Secretary of Defense, and respond to questions from Congressional officials. In my role as Deputy Chief, AFHSB, I ensure that reports, documents and COVID-19 related policy reviews are accurate and produced in a timely fashion from AFHSB’s three sections. Since February 2020, I’ve reviewed and provided input to nearly 70 executive summaries , several information and position papers, and at least 20 weekly surveillance summaries addressing COVID-19 issues.

Where have you traveled in this role?

My travel is mainly limited to the National Capital Region. I’ve participated in tabletop drills such as an interagency simulation for Crimson Contagion, a response to a severe influenza pandemic. I’ve also served as a representative to the Defense Health Board to evaluate health surveillance matters such as COVID-19 and respiratory infections in support of DHA’s Combat Support Agency mission.

You also may be interested in...

Consolidated Department of Defense Coronavirus Disease 2019 Force Health Protection Guidance

Policy

Consolidates and updates the Department’s guidance regarding vaccination verification, vaccination status, COVID-19 testing, surveillance and screening testing, personnel protection on-site mask requirements, (e.g., DHA military medical treatment facilities, meetings, travel), and the protection of personally identifiable information.

  • Identification #: 22-006
  • Date: 8/18/2022
  • Type: Memorandums
  • Topics: COVID-19

DHA-IPM 20-004: Department of Defense (DOD) Coronavirus Disease 2019 (COVID-19) Vaccination Program Implementation

Policy

Establishes the Defense Health Agency’s procedures to implement instructions, assign responsibilities, and prescribe procedures for the DHA’s implementation of the DOD’s COVID-19 Vaccination Program.

  • Identification #: DHA-IPM 20-004
  • Date: 6/16/2022
  • Type: DHA Interim Procedures Memorandum
  • Topics: COVID-19

Coronavirus Disease 2019 Vaccination Attestation, Screening Testing, and Vaccination Verification

Policy

This memorandum provides guidance on the implementation of vaccination, attestation, and testing requirements in accordance with the References listed in Attachment 1 to reduce the transmission of the virus that causes COVID-19.

  • Identification #: 21-004
  • Date: 11/3/2021
  • Type: Memorandums
  • Topics: COVID-19

Medical Logistics Guidance for the DoD Coronavirus Disease 2019 (COVID-19) Vaccination Program

Policy

Establishes the DHA's procedures for ordering, receiving, and managing COVID-19 Vaccines inventory and ancillary kits for enduring COVID-19 support.

  • Identification #: 6025.01
  • Date: 5/10/2021
  • Type: DHA Procedural Instruction
  • Topics: COVID-19

TAB A MEO COVID19 Medical Coding Policy

Policy

Memorandum for DHA Staff - Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

  • Identification #: N/A
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: COVID-19

DHA COVID19 Medical Coding PolicyV5 1v

Policy

Establishes the DHA procedures to standardize the coding for Coronavirus 2019 (COVID-19) within military medical treatment facilities (MTFs). This memorandum replaces DHA-Policy Memorandum 20-003 of July 1, 2020. Attachment 1 was updated to include the 2021 procedure and diagnosis codes for COVID-19, including the new vaccination and treatment codes.

  • Identification #: 20-003
  • Date: 3/25/2021
  • Type: Memorandums
  • Topics: COVID-19

Supplemental Guidance for Providing DOD Coronavirus Disease 2019 Vaccines to DOD Contractor Employees and Select Foreign Nationals

Policy

This memorandum provides supplemental guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines, in accordance with reference (a). The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components as appropriate.

  • Identification #: N/A
  • Date: 12/31/2020
  • Type: Memorandums
  • Topics: COVID-19

HA Guidance for Coronavirus Disease 2019 (COVID-19) Laboratory Pre-Testing Questionnaire

Policy

This memorandum provides guidance for a COVID-19 laboratory pre-testing questionnaire that will be mandatory for all Active Duty Service members and encouraged for all other DOD beneficiaries treated at military medical treatment facilities.

  • Identification #: N/A
  • Date: 12/17/2020
  • Type: Memorandums
  • Topics: COVID-19

Executive Order on Ensuring Access to United States Government COVID-19 Vaccines

Policy

This EO outlines who should receive priority access to COVID-19 vaccines developed in the United States or procured by the United States Government (“United States Government COVID-19 Vaccines”).

  • Identification #: N/A
  • Date: 12/8/2020
  • Type: Directives
  • Topics: COVID-19

Coronavirus Disease 2019 Vaccine Guidance

Policy

This memorandum provides guidance on the provision of coronavirus disease 2019 (COVID-19) vaccines. The Defense Health Agency (DHA) is the lead coordinating DOD Component for executing this guidance, in coordination with the Military Departments and other DOD Components.

  • Identification #: N/A
  • Date: 12/7/2020
  • Type: Memorandums
  • Topics: COVID-19

Return to the Workplace Staffing Plan in the Coronavirus Disease 2019 Environment

Policy

Establishes the DHA's plan to return to full operations and support the whole-of-government response, during the Coronavirus Disease 2019 (COVID-19) pandemic

  • Identification #: 3020.01
  • Date: 11/3/2020
  • Type: Administrative Instructions
  • Topics: COVID-19

Military Medical Treatment Facilities to Implement Updated DHA COVID-19 Medical Coding Policy

Policy

The Defense Health Agency (DHA) Memorandum, based on the authority of References (a) and (b), and in accordance with the guidance of References (c) and (d), establishes the DHA’s procedures to standardize the coding for Coronavirus 2019 (COVID-19) Military Medical Treatment Facilities (MTFs). This memorandum cancels and replaces DHA- Policy Memorandum 20-003 of (13 April 2020). A change was issued since the cancelled Memorandum 20-003 of (13 April 2020), the Attachment titles were updated to reflect that Attachments 1, 2, and 4 are considered Policies as opposed to Guidance.

  • Identification #: 20-003
  • Date: 5/13/2020
  • Type: Memorandums
  • Topics: COVID-19

Armed Forces Reportable Medical Events Guidelines and Case Definitions Memo

Policy

The Armed Forces Reportable Medical Events Guidelines and Case Definitions (RME Guidelines) standardize reporting and tracking of disease and other conditions of public health and military importance. Timely reporting permits earlier recognition of public health events and interventions to protect the health of the force.

Establishing an Armed Forces Health Surveillance Center

Policy

Establishing an Armed Forces Health Surveillance Branch." In accordance with DoD Directive 5101,1, "DoD Executive Agent" September 3, 2002, this memorandum designates the Secretary of the Army as the DoD Executive Agent for the AFHSB, which includes the Defense Medical Surveillance System and the DoD Serum Repository. . . The DoD EA shall further ensure that the Center POC aligns and integrates the current surveillance activities of the Army Medical Surveillance Activity and the DoD Global Emerging Infections Surveillance and Response System with surveillance activities of the DoD Deployment Health Support Directorate.

Page 1 of 1 , showing items 1 - 14
Refine your search
Last Updated: August 22, 2022
Follow us on Instagram Follow us on LinkedIn Follow us on Facebook Follow us on Twitter Follow us on YouTube Sign up on GovDelivery